Clinical trials in diabetes have also improved data capture, safety and accessibility using new mobile health platforms, specifically hybrid and virtual trial technology.
TORONTO (PRWEB) April 14, 2020
The management landscape for Diabetes Mellitus (both Type 1 and Type 2) has changed drastically. Innovations in the mobile health technology space have allowed patients with diabetes to have improved glycemic control with more data available to them and their providers. Clinical trials in diabetes have also improved data capture, safety and accessibility using new mobile health platforms, specifically hybrid and virtual trial technology.
This educational webinar will provide an overview of the mobile health technology space, highlighting current innovations and challenges. The webinar will review recent clinical research experiences and explore the current state of these technologies in T1DM and T2DM.
- Barry Goldstein, MD, PhD, FACE, Vice President & Therapeutic Area Head, Cardiovascular, Metabolic, Endocrinology & Renal
- Manasi Jaiman, MD, MPH, Senior Medical Director, Cardiovascular, Metabolic, Endocrinology & Renal
- Bola Oyegunwa, PhD, MBA, Vice President and Global Head of Hybrid and Virtual Trials
For more information or to register for this event, visit Mobile Health and Hybrid/Virtual Trials in Diabetes.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.